MetaCap

Editas Medicine Balance Sheet

NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.64-0.07 (-4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Editas Medicine financial position

At the end of fiscal 2025, Editas Medicine reported total assets of $186.5 million, down 45.4% from a year earlier against total liabilities of $159.2 million. Shareholders' equity stood at $27.3 million, or 14.6% of assets. The company held $146.6 million in cash and equivalents against $58.6 million of debt, a net cash position of $88.0 million.

The current ratio (current assets divided by current liabilities) was 3.54, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.15.

Summary generated from market data by MetaCap's automated system. Methodology

Editas Medicine balance sheet (annual)

Editas Medicine annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31FY 20162016-12-31
Cash & Equivalents146.65M131.54M123.65M141.52M203.52M139.68M238.18M134.78M146.63M185.32M
Short-Term Investments0138.37M199.46M202.75M296.33M262.43M218.96M234.18M182.51M—
Receivables15.18M16.27M10.19M5.14M267.00K6.05M418.00K30.00K679.00K88.00K
Total Current Assets163.90M289.31M340.83M356.75M507.31M419.09M463.84M374.78M332.20M187.18M
Property, Plant & Equipment3.54M14.50M12.03M15.57M17.12M14.02M10.89M40.23M39.44M40.38M
Long-Term Investments—0104.02M93.10M120.07M109.66M————
Total Assets186.53M341.59M499.15M514.32M677.48M572.60M508.88M420.39M373.26M229.18M
Accounts Payable2.60M5.49M8.27M9.51M5.05M6.41M5.84M5.33M4.02M4.64M
Short-Term Debt5.00M5.00M0———————
Total Current Liabilities46.25M77.22M63.22M60.11M46.88M58.21M59.96M35.90M36.71M33.08M
Long-Term Debt53.60M52.43M0———————
Total Liabilities159.25M207.31M150.06M153.64M123.84M179.02M246.45M184.22M165.18M94.58M
Shareholders' Equity27.29M134.27M349.10M360.68M553.64M393.59M262.44M236.16M208.08M134.61M
Retained Earnings-1.63B-1.47B-1.23B-1.08B-857.70M-665.20M-549.22M-416.28M-305.85M-185.53M
Total Debt58.60M57.43M0———————
Net Cash (Debt)88.04M212.48M323.11M344.27M499.85M402.11M457.14M368.95M329.14M185.32M
Shares Outstanding97.87M82.73M81.77M68.85M68.44M62.56M54.36M48.76M44.51M35.82M

This table shows 10 annual periods of Editas Medicine's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow EDIT's reporting calendar. What is a balance sheet?

More financial data